- Bristol and Simcere expand drug-development partnership
Bristol-Myers Squibb agreed with Chinese company Simcere Pharmaceutical Group to develop BMS-795311, a drug that might enhance HDL, or "good" cholesterol. The deal gives Simcere exclusive Chinese rights to the compound. Last year, the drugmakers agreed to work on a cancer treatment. PharmaTimes (U.K.) (12/14)        | John Jantsch invites you to go local
As customers continue to rely on the Web to help them screen local businesses, local businesses must take steps to ensure that they pop to the top of online searches. Duct Tape Marketing's John Jantsch offers strategies for local marketing success in this free white paper from American Express OPEN, How to Win at the Local Marketing Game. Download your free copy now, exclusively for SmartBrief readers. |
 - Study associates stem cell aging with blood cancers in older people
Stem cell aging could be the reason older people are at greater risk of myeloid malignancies and more susceptible to rhinoviruses, flu and other infections, according to a study in the Proceedings of the National Academy of Sciences. Researchers found that hematopoietic stem cells from healthy seniors tend to produce fewer immunoprotective lymphocytes and make more myeloid cells compared with stem cells from healthy younger people, and this could result in weaker immune responses and blood cancers, including acute myeloid leukemia. Oncology Nurse Advisor online (12/13) - Study rejects link between gene polymorphisms and flu deaths
A study showed that polymorphisms in the tumor necrosis factor and mannose-binding lactin genes are not associated with flu-related deaths of children and young adults. However, "among the case-patients who died, most of whom died in childhood, variants of MBL2 responsible for low production of MBL were associated with MRSA co-infection," researchers found. The findings appeared in the CDC's Emerging Infectious Diseases. DoctorsLounge.com/HealthDay News (12/14)  | The Changing Role of Chemistry in Drug Discovery
This Thomson Reuters report delivers an in-depth review of the changing role of Chemistry and of Chemists in today's drug discovery research programs. With input from many key pharmaceutical industry players, supported with data from Thomson Reuters IntegritySM, it examines how life in drug discovery has changed and how it will continue to adapt in the future. Access the report here! |
 - Pharma emulates automakers to boost profit and innovation
GlaxoSmithKline and AstraZeneca are using the operational expertise of automakers as the industry faces research budget cuts and smaller profits. According to this analysis, big automakers' retreat to a focus on core operations may hold lessons for the pharmaceutical industry. Reuters (12/14)  - Lineagen, Fast Forward partner to develop MS test
Lineagen is teaming up with FastForward, the nonprofit subsidiary of the National Multiple Sclerosis Society, to develop a biomarker-based test for MS. FastForward will contribute $622,000 toward the validation of MS biomarkers, including genes that increase susceptibility to MS and blood-based markers that could be used for diagnosis and prognosis. Genetic Engineering & Biotechnology News (12/14)  | Enterprise Asset Management: Cost Avoidance
Timothy Biernacki of Baker Energy speaks about asset management, and his approach in building an overall maintenance management strategy and philosophy. Proper usage of an asset management system can help maximize the utilization of both operating and IT assets and help reduce cost and ultimately provide solid return on asset. Learn more. |
| Food & Agriculture |  |  | | - Biotechnology needed to meet future food needs, says U.S. senator
The use of biotechnology in farming, together with good government policies, is necessary to meet future global demand, Sen. Dick Lugar, R-Ind., said of a McKinsey Global Institute report on the outlook for world's food supply. "Given the challenges of altered weather patterns, future water scarcity, new pests and diseases, and the need for more nutritious plants, we must use all the technology in our toolbox, including bioengineered seeds," he said. Lugar also asked European governments to stop resisting the use of biotechnology and lift bans on biotech plants. Agri-Pulse.com (12/13) | Industrial & Environmental | | | | | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is saving 2,700 companies nationwide on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot, Business Wire are just a few of the industry leading providers that offer special pricing through this members only program. Learn more or enroll here.
| SmartQuote | | | |  | You'll never plow a field by turning it over in your mind."
|
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, December 14, 2011
- Tuesday, December 13, 2011
- Monday, December 12, 2011
- Friday, December 09, 2011
- Thursday, December 08, 2011
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment